Suppr超能文献

从心跳停止后捐献中获取的心脏移植:对等候名单时间和移植率的影响。

Heart transplantation from donation after circulatory death: Impact on waitlist time and transplant rate.

机构信息

University of the Incarnate Word School of Osteopathic Medicine, San Antonio, Texas, USA; Autonomous Reanimation and Evacuation (AREVA) Research Program and Innovation Center, The Geneva Foundation, San Antonio, Texas, USA.

Division of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla, California, USA.

出版信息

Am J Transplant. 2023 Aug;23(8):1241-1255. doi: 10.1016/j.ajt.2023.04.026. Epub 2023 Apr 28.

Abstract

The effect of using donation after circulatory death (DCD) hearts on waitlist outcomes has not been substantiated. We retrospectively analyzed 184 heart transplant (HT) candidates at our institution from 2019 to 2021. Patients were stratified into 2 observation periods centered on September 12, 2020, when the adult DCD HT program officially began. The primary outcome was a comparison of transplant rate between period 1 (pre-DCD) and period 2 (post-DCD). Secondary outcomes included waitlist time-to-transplant, waitlist mortality rate, independent predictors of incidence of HT, and posttransplant outcomes. A total of 165 HTs (n = 92 in period 1 and n = 73 in period 2) were performed. The median waitlist time-to-transplant decreased from 47.5 to 19 days in periods 1 and 2, respectively (P = .004). The transplant rate increased from 181 per 100 patient-years in period 1 to 579 per 100 patient-years in period 2 (incidence rate ratio, 1.87; 95% CI, 1.04-3.38; P = .038). There were no statistical differences in waitlist mortality rate (P = .566) and 1-year survival (P = .699) between the 2 periods. DCD HTs (n = 36) contributed to 49.3% of overall HT activity in period 2. We concluded that utilization of DCD hearts significantly reduced waitlist time and increased transplant rate. Short-term posttransplant outcomes were comparable between the pre-DCD and post-DCD periods.

摘要

使用循环死亡供体(DCD)心脏对等待名单结果的影响尚未得到证实。我们回顾性分析了 2019 年至 2021 年在我院的 184 例心脏移植(HT)候选者。患者分为 2 个观察期,以 2020 年 9 月 12 日为中心,当时成人 DCD-HT 项目正式开始。主要结果是比较第 1 期(DCD 前)和第 2 期(DCD 后)的移植率。次要结果包括等待移植时间、等待移植死亡率、HT 发生率的独立预测因素和移植后结果。共进行了 165 例 HT(n=92 例在第 1 期,n=73 例在第 2 期)。第 1 期和第 2 期的中位等待移植时间分别从 47.5 天降至 19 天(P=0.004)。移植率从第 1 期的每 100 例患者年 181 例增加到第 2 期的每 100 例患者年 579 例(发生率比,1.87;95%CI,1.04-3.38;P=0.038)。两个时期的等待移植死亡率(P=0.566)和 1 年生存率(P=0.699)无统计学差异。DCD-HT(n=36)占第 2 期总 HT 活动的 49.3%。我们得出结论,使用 DCD 心脏显著缩短了等待名单时间并增加了移植率。DCD 前后短期移植后结果相当。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验